等待开盘 10-28 09:30:00 美东时间
0.000
0.00%
Immatics N.V. announced the appointment of Venkat Ramanan, Ph.D., as Chief Financial Officer, effective immediately, to succeed Arnd Christ. With over 25 years of experience in the biopharmaceutical industry, Ramanan will support the company's advancement of its PRAME franchise and commercialization of anzu-cel for patients with metastatic melanoma.
10-01 11:00